Alan K. Smith
2019
In 2019, Alan K. Smith earned a total compensation of $791.7K as Executive Vice President, Technology Operations at BELLICUM PHARMACEUTICALS, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $63,750 |
|---|---|
| Option Awards | $255,251 |
| Salary | $388,087 |
| Other | $84,590 |
| Total | $791,678 |
Smith received $388.1K in salary, accounting for 49% of the total pay in 2019.
Smith also received $63.8K in non-equity incentive plan, $255.3K in option awards and $84.6K in other compensation.
Rankings
In 2019, Alan K. Smith's compensation ranked 10,257th out of 13,971 executives tracked by ExecPay. In other words, Smith earned more than 26.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,257 out of 13,971 | 27th |
Division Manufacturing | 4,152 out of 5,701 | 27th |
Major group Chemicals And Allied Products | 1,590 out of 2,200 | 28th |
Industry group Drugs | 1,361 out of 1,886 | 28th |
Industry Pharmaceutical Preparations | 1,011 out of 1,398 | 28th |
Source: SEC filing on April 27, 2020.
Smith's colleagues
We found three more compensation records of executives who worked with Alan K. Smith at BELLICUM PHARMACEUTICALS in 2019.